Upcoming Events

ACT Upcoming Events


  • Thursday
    21
    March

    eLearning: Module 2–Development of Small Molecule Therapeutics for CNS Diseases

    Mar 21, 11:00 AM - 12:30 PM (ET)

    The American College of Toxicology is proud to offer a new eLearning Seminar focused on development of CNS/Neurology Therapeutics. These four modules are intended to provide insight into the development of therapeutics for CNS/Neurology diseases, focusing on the regulatory and nonclinical considerations for safety assessment of therapies encompassing standard and novel modalities, including small molecules, biologics, anti-sense oligonucleotides (ASOs)/miRNA, and advanced cell and gene therapies.

    Module 1: Regulatory Considerations for the Development of CNS/Neurology Therapeutics 
    Module 2: Development of Small Molecule Therapeutics for CNS Diseases
    Module 3: Development of Advanced CNS/Neurology Therapeutics
    Module 4: Development of Biologics for CNS Diseases

    For more information and registration, please visit: ACT eLearning

  • Wednesday
    27
    March

    Signature Webinar: Nerve Conduction Studies to Evaluate Neuropathy in Nonclinical Safety Assessment

    Mar 27, 11:30 AM - 01:00 PM (ET)

    Neuropathy refers to any condition involving peripheral nervous system damage and can develop as a side effect of certain classes of therapeutic compounds, from toxin exposure, or due to disease. Given the clinical significance of neuropathy, it can be critical to characterize nerve function during the nonclinical safety assessment of certain classes of compounds. In addition, recent characterization of dorsal root ganglion toxicity following AAV (adeno-associated virus) therapies stresses the need to have an in-vivo assessment of potential nerve damage on these studies. Nerve conduction studies provide an electrophysiological approach to assess nerve function. They have been shown to be a sensitive and valid index of induced neuropathies, can be conducted at multiple time points throughout the treatment period, and provide quantitative data for evaluation. In this talk, we will provide an overview of nerve conduction study theory and practice in nonclinical safety assessment as well as highlight study design considerations, positive control validation data, and case study examples.

    Speakers:

    Andrew Brown, PhD

    Nataliya Sadekova, MSc

    There is no fee, but advance registration is required.

    For more information and registration, please visit ACT Webinar.

  • Monday
    8
    April

    Toxicology for Pharmaceutical and Regulatory Scientists

    Apr 8 - 12, (ET)

    This annual ACT course provides basic training in general toxicology. Participants will obtain an overall understanding of the principles of toxicology and nonclinical safety evaluation with a focus on pharmaceutical development. By popular demand, the course will include discussion of regulatory case studies and hands-on analyses of nonclinical data. The course is intended to benefit individuals working with small and large molecules from biotechnology and pharmaceutical companies, CROs, and regulatory agencies, or individuals interested in or currently practicing toxicology.

    Herndon, VA, United States

  • Thursday
    25
    April

    eLearning: Module 3–Development of Advanced CNS/Neurology Therapeutics

    Apr 25, 11:00 AM - 12:30 PM (ET)

    The American College of Toxicology is proud to offer a new eLearning Seminar focused on development of CNS/Neurology Therapeutics. These four modules are intended to provide insight into the development of therapeutics for CNS/Neurology diseases, focusing on the regulatory and nonclinical considerations for safety assessment of therapies encompassing standard and novel modalities, including small molecules, biologics, anti-sense oligonucleotides (ASOs)/miRNA, and advanced cell and gene therapies.

    Module 1: Regulatory Considerations for the Development of CNS/Neurology Therapeutics 
    Module 2: Development of Small Molecule Therapeutics for CNS Diseases 
    Module 3: Development of Advanced CNS/Neurology Therapeutics
    Module 4: Development of Biologics for CNS Diseases

    For more information and registration, please visit: ACT eLearning

  • Monday
    6
    May

    Pathology for Nonpathologists

    May 6 - 8, (ET)

    This joint American College of Toxicology and Society of Toxicologic Pathology course, held every other year, provides lectures given by highly respected pathologists with current, relevant experience in toxicologic pathology. Lectures will cover anatomy and physiology, spontaneous and chemically induced pathological changes, and clinical pathology. The knowledge gained will be immediately applicable to your day-to-day practices. Different organs or systems are featured in subsequent courses.This joint American College of Toxicology and Society of Toxicologic Pathology course, held every other year, provides lectures given by highly respected pathologists with current, relevant experience in toxicologic pathology. Lectures will cover anatomy and physiology, spontaneous and chemically induced pathological changes, and clinical pathology. The knowledge gained will be immediately applicable to your day-to-day practices. Different organs or systems are featured in subsequent courses.

    Herndon, VA, United States

  • Thursday
    16
    May

    eLearning: Module 4–Development of Biologics for CNS Diseases

    May 16, 11:00 AM - 12:30 PM (ET)

    The American College of Toxicology is proud to offer a new eLearning Seminar focused on development of CNS/Neurology Therapeutics. These four modules are intended to provide insight into the development of therapeutics for CNS/Neurology diseases, focusing on the regulatory and nonclinical considerations for safety assessment of therapies encompassing standard and novel modalities, including small molecules, biologics, anti-sense oligonucleotides (ASOs)/miRNA, and advanced cell and gene therapies.

    Module 1: Regulatory Considerations for the Development of CNS/Neurology Therapeutics 
    Module 2: Development of Small Molecule Therapeutics for CNS Diseases 
    Module 3: Development of Advanced CNS/Neurology Therapeutics
    Module 4: Development of Biologics for CNS Diseases

    For more information and registration, please visit: ACT eLearning

  • Tuesday
    31
    December

    Basic Topics in Toxicology eLearning Seminar

    Dec 31, 09:00 AM - 11:59 PM (ET)
    eLearning Seminar: Basic Topics in Toxicology

    Registration open now until December 31, 2024!

    To further its mission to educate, lead, and serve, the American College of Toxicology is offering a new eLearning Seminar focused on the basic topics in toxicology. Basic Topics consists of nine modules that is aimed to provide a strong foundation for an in-depth understanding of the basic concepts and principles of toxicology, pharmacology, drug metabolism, and pharmacokinetics. These modules feature recorded presentations by recognized experts in the field.

    Modules are available for purchase as a set. Each module is about 90 minutes or less in duration.